Pathlight Investors’s GSK GSK Stock Holding History

Pathlight Investors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$675K	Buy	+13,771	New	+$678K	0.56%	37

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Pathlight Investors's GSK Position: Q4 2018 in Review

Pathlight Investors opened a new position in GSK (GSK) in Q4 2018: 13,771 shares worth $675K. The stake represents 0.56% of the portfolio and ranks #37 among its holdings.

800 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

Pathlight Investors held 13,771 shares of GSK worth $675K as of Q4 2018.
GSK was a new Pathlight Investors position in Q4 2018.
GSK made up 0.56% of Pathlight Investors's portfolio in Q4 2018, its #37 holding.
800 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Pathlight Investors's 13F filing for Q4 2018, filed 19 Feb 2019.